norcantharidin has been researched along with Colonic Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, YZ; Jing, W; Li, XP; Liu, ZY; Sun, JJ; Sun, W; Zhang, JT; Zhu, W | 1 |
| Agrez, M; Gao, C; Gao, H; He, Z; Li, Z; Lin, P; Niu, J; Niu, W; Niu, Z; Peng, C; Wang, J; Xu, Z; Zhang, Z | 1 |
| Cui, Y; He, Y; Liu, M; Ma, H; Qiu, P; Tang, Y; Wang, S; Xu, H; Xu, L; Zeng, X; Zhang, L; Zhang, M | 1 |
| Agrez, M; Chen, R; Lin, P; Liu, E; Liu, X; Niu, J; Niu, W; Peng, C; Wang, J; Xu, K; Zhang, Z | 1 |
4 other study(ies) available for norcantharidin and Colonic Neoplasms
| Article | Year |
|---|---|
A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Endothelial Cells; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; In Vitro Techniques; Lymphangiogenesis; Lymphatic Metastasis; Mice; Mice, Nude; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factors; Xenograft Model Antitumor Assays | 2015 |
Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling Pathway.
Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; MAP Kinase Signaling System; Proto-Oncogene Protein c-ets-1 | 2016 |
Norcantharidin Inhibits cell growth by suppressing the expression and phosphorylation of both EGFR and c-Met in human colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; ErbB Receptors; G2 Phase Cell Cycle Checkpoints; Gefitinib; HCT116 Cells; HT29 Cells; Humans; Phosphorylation; Proto-Oncogene Proteins c-met; Quinazolines | 2017 |
Norcantharidin induces HT-29 colon cancer cell apoptosis through the alphavbeta6-extracellular signal-related kinase signaling pathway.
Topics: Antigens, Neoplasm; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Colonic Neoplasms; Extracellular Signal-Regulated MAP Kinases; HT29 Cells; Humans; Integrins; Signal Transduction | 2009 |